Patents by Inventor AI-MIN HUI

AI-MIN HUI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for cancer therapy
    Patent number: 11241448
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: February 8, 2022
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Ai-Min Hui, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • METHODS FOR CANCER THERAPY
    Publication number: 20210177871
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: March 1, 2021
    Publication date: June 17, 2021
    Inventors: Ai-Min Hui, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • Methods for Cancer Therapy
    Publication number: 20200171061
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: February 4, 2020
    Publication date: June 4, 2020
    Inventors: Ai-Min Hui, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • METHODS FOR CANCER THERAPY
    Publication number: 20190343851
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: July 22, 2019
    Publication date: November 14, 2019
    Inventors: AI-MIN HUI, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • METHODS FOR CANCER THERAPY
    Publication number: 20190125773
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: December 21, 2018
    Publication date: May 2, 2019
    Inventors: AI-MIN HUI, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • METHOD FOR CANCER THERAPY
    Publication number: 20150335668
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: May 19, 2015
    Publication date: November 26, 2015
    Inventors: AI-MIN HUI, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Lui